Kontafarma China Holdings Limited (HKG:1312)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.0280
0.00 (0.00%)
At close: Mar 10, 2026
-6.67%
Market Cap 156.48M
Revenue (ttm) 891.73M
Net Income (ttm) -362.77M
Shares Out 5.59B
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 1,559,100
Open n/a
Previous Close 0.0280
Day's Range n/a
52-Week Range 0.0200 - 0.0480
Beta -0.00
RSI 30.98
Earnings Date Mar 27, 2026

About Kontafarma China Holdings

Kontafarma China Holdings Limited, an investment holding company, manufactures and sells chemical drugs, active pharmaceutical ingredients (API), and API intermediate in Mainland China, Singapore, Taiwan, and internationally. It operates through Pharmaceutical Business and Fitness Business segments. The company offers prescription drugs, including chemical drugs and prescribed traditional Chinese medicines; operates fitness and yoga centers, as well as franchise business; and provides management and consultation services for fitness and health ... [Read more]

Sector Healthcare
Founded 2011
Employees 655
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1312
Full Company Profile

Financial Performance

In 2024, Kontafarma China Holdings's revenue was 897.52 million, an increase of 10.93% compared to the previous year's 809.11 million. Losses were -75.54 million, 161.9% more than in 2023.

Financial Statements

News

There is no news available yet.